iShares Global Healthcare ETF
IXJDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 18, 2026 | $0.85 | 2026-06-15 | 2026-06-15 |
| December 19, 2025 | $0.60 | 2025-12-16 | 2025-12-16 |
| June 20, 2025 | $0.76 | 2025-06-16 | 2025-06-16 |
| December 20, 2024 | $0.62 | 2024-12-17 | 2024-12-17 |
| June 17, 2024 | $0.67 | 2024-06-11 | 2024-06-11 |
Dividends Summary
- Consistent Payer: iShares Global Healthcare ETF has rewarded shareholders with 41 dividend payments over the past 18 years.
- Total Returned Value: Investors who held IXJ shares during this period received a total of $25.60 per share in dividend income.
- Latest Payout: The most recent dividend of $0.85/share was paid 30 days ago, on June 18, 2026.
- Dividend Growth: Since 2008, the dividend payout has decreased by 15.7%, from $1.00 to $0.85.
Company News
The iShares Global Healthcare ETF (IXJ) outperformed the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) over the past five years, delivering stronger total returns (1.50% dividend yield vs. 0.70%), lower volatility (beta of 0.56 vs. 0.78), and a shallower maximum drawdown. While both funds charge identical 0.40% expense ratios, IXJ's market-...
Fidelity MSCI Health Care Index ETF (FHLC) and iShares Global Healthcare ETF (IXJ) are compared as healthcare investment options. FHLC offers lower costs (0.08% expense ratio) with domestic-only focus and stronger 5-year performance (10.6% annualized returns), while IXJ provides international diversification but charges higher fees (0.40%). The a...
IHE (U.S. Pharmaceuticals ETF) significantly outperformed IXJ (Global Healthcare ETF) over the past year, driven largely by GLP-1 drug success, particularly from Eli Lilly. While IHE's concentrated focus on domestic pharma delivered 39.70% returns, IXJ's broader global healthcare approach provided more diversification but only 10% returns. Both f...
The Trump administration is investigating Medicaid spending in California and five other Democratic-led states, focusing on potential improper billings for immigrant healthcare services. California faces potential enforcement actions after self-reporting $500 million in billing errors, which could lead to significant program cuts.
